バイオ医薬品ロジスティクス市場：製品、輸送、輸送手段別-2025-2030年の世界予測

バイオ医薬品ロジスティクス市場は、2023年に152億1,000万米ドルと評価され、2024年には169億2,000万米ドルに達すると予測され、CAGR 11.29%で成長し、2030年には321億8,000万米ドルに達すると予測されています。

バイオ医薬品ロジスティクス分野は、厳格な温度管理、特殊な取り扱い、タイムリーな配送を必要とするドラッグや生物製剤の輸送、保管、流通を網羅しています。この業界の重要性は、温度変化に敏感なワクチン、生物製剤、複雑な医薬品の完全性と有効性を、製造業者から病院、薬局、診療所などのエンドユーザーまで維持する必要性によって強調されています。この分野の主なアプリケーションには、コールドチェーン・ロジスティクス、サプライチェーン管理、貨物輸送が含まれ、製品が規制基準に準拠して安全に到着することを保証します。最終用途は製薬会社、ヘルスケアプロバイダー、研究機関など多岐にわたり、効率的なロジスティクスによって医薬品へのアクセスや入手が容易になります。

市場成長は、医薬品研究開発活動の活発化、慢性疾患の世界の増加、個別化医療の出現に大きく影響されています。生物製剤やバイオシミラーの普及に加え、先進パッケージング技術やリアルタイムデータモニタリングソリューションの進歩は、この市場に革新的なサービスを提供する大きな機会をもたらしています。こうした機会を活用するため、企業は追跡を強化するためのIoTやAI、透明性の高いサプライチェーンを実現するためのブロックチェーンなど、次世代ロジスティクス技術の導入に注力すべきです。しかし、課題としては、運用コストの高さ、規制要件の厳しさ、生物製剤の取り扱いの複雑さなどがあり、これらは市場参入や拡大の障壁となり得る。

技術革新の面では、企業は環境問題に対処するため、より持続可能で環境に優しいロジスティクス・ソリューションへの投資を検討することができます。これには、より効率的な低温貯蔵ソリューションの開発や、サプライチェーン内での再生可能エネルギーの活用などが含まれます。さらに、ロジスティクス業務を合理化する統合デジタル・プラットフォームのためのハイテク企業とのコラボレーションは、競争力を提供する可能性があります。市場は、激しい競争と急速な技術進歩によって特徴付けられ、先を行くためには敏捷性と戦略的パートナーシップを必要とします。そこには、業界プレーヤーがサプライチェーンの透明性と効率性を高め、競争力学を再定義し、市場リーチを最適化できる可能性があります。

市場力学：急速に進化するバイオ医薬品ロジスティクス市場の主要な市場洞察の解明

バイオ医薬品ロジスティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオ医薬品業界における細胞療法、ワクチン、血液製剤の需要拡大
  • 高い売上高がバイオ医薬品の世界の輸出輸入需要を牽引
  • ヘルスケア分野での迅速支援の重要性の高まり
• 市場抑制要因
  • 輸送コストの高さ
• 市場機会
  • ロジスティクスの継続的な革新とクラウドコンピューティングの統合
  • 輸送サービスのアウトソーシング需要の高まり
• 市場の課題
  • 非効率な製品と価格政策の変動

ポーターの5つの力：バイオ医薬品ロジスティクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオ医薬品ロジスティクス市場における外部からの影響の把握

外部マクロ環境要因は、バイオ医薬品ロジスティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオ医薬品ロジスティクス市場における競合情勢の把握

バイオ医薬品ロジスティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオ医薬品ロジスティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオ医薬品ロジスティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオ医薬品ロジスティクス市場における成功への道筋を描く

バイオ医薬品ロジスティクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ医薬品業界における細胞治療、ワクチン、血液製剤の需要の拡大
    • 高い売上高によりバイオ医薬品の世界の輸出入需要が増加
    • ヘルスケア分野における迅速な支援の重要性の高まり
  • 抑制要因
    • 輸送コストが高い
  • 機会
    • クラウドコンピューティングのロジスティクスと統合における継続的なイノベーション
    • 輸送サービスのアウトソーシング需要の高まり
  • 課題
    • 非効率的な製品と価格政策の変動
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオ医薬品ロジスティクス市場：製品別

• ブランド医薬品
• ジェネリック医薬品

第7章 バイオ医薬品ロジスティクス市場交通機関

• コールドチェーン輸送
• 非コールドチェーン輸送

第8章 バイオ医薬品ロジスティクス市場：交通手段別

• 航空輸送
• 鉄道輸送
• 陸上輸送
• 海上輸送

第9章 南北アメリカのバイオ医薬品ロジスティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のバイオ医薬品ロジスティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのバイオ医薬品ロジスティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AmerisourceBergen Corporation
• Bio Pharma Logistics
• BL Turkey
• C.H. Robinson Worldwide, Inc.
• CAVALIER LOGISITICS
• Ceva Logistics LLC
• DB Schenker AG
• Deutsche Post DHL Group
• Fedex Corporation
• Kerry Logistics Network Limited
• Kuhne+Nagel Management AG
• Nippon Express Co., Ltd.
• Sentry BioPharma Services, Inc.
• United Parcel Service of America, Inc.

LIST OF FIGURES

• FIGURE 1. BIO-PHARMACEUTICAL LOGISTICS MARKET RESEARCH PROCESS
• FIGURE 2. BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIO-PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIO-PHARMACEUTICAL LOGISTICS MARKET DYNAMICS
• TABLE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 145. BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Bio-Pharmaceutical Logistics Market was valued at USD 15.21 billion in 2023, expected to reach USD 16.92 billion in 2024, and is projected to grow at a CAGR of 11.29%, to USD 32.18 billion by 2030.

The bio-pharmaceutical logistics sector encompasses the transportation, storage, and distribution of drugs and biologics that require stringent temperature controls, specialized handling, and timely deliveries. This industry's criticality is underscored by the necessity to maintain the integrity and efficacy of temperature-sensitive vaccines, biologics, and complex medicines from manufacturers to end-users, including hospitals, pharmacies, and clinics. Key applications within this domain include cold chain logistics, supply chain management, and freight forwarding, ensuring that products arrive safely and in compliance with regulatory standards. The end-use scope is expansive, spanning pharmaceutical companies, healthcare providers, and research organizations that rely on efficient logistics to facilitate the accessibility and availability of medications.

Market growth is significantly influenced by increased pharmaceutical R&D activities, a rise in the global incidences of chronic diseases, and the advent of personalized medicine. The proliferation of biologics and biosimilars, alongside advancements in packaging technologies and real-time data monitoring solutions, present substantial opportunities for innovative service offerings in this market. To leverage these opportunities, companies should focus on adopting next-generation logistics technologies, such as IoT and AI for enhanced tracking, and blockchains for transparent supply chains. However, challenges include high operational costs, stringent regulatory requirements, and the complexity of handling biologics, which can pose barriers to market entry and expansion.

In terms of innovation, companies can explore investing in more sustainable and eco-friendly logistics solutions to address environmental concerns. This includes developing more efficient cold storage solutions and utilizing renewable energy sources within the supply chain. Additionally, collaborations with tech firms for integrated digital platforms that streamline logistics operations could offer a competitive edge. The market is characterized by robust competition and rapid technological advancements, necessitating agility and strategic partnerships to remain ahead. Therein lies an opportunity for industry players to enhance supply chain transparency and efficiency, potentially redefining competitive dynamics and optimizing market reach in the bio-pharmaceutical logistics sphere.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bio-Pharmaceutical Logistics Market

The Bio-Pharmaceutical Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expansion in the demand for cellular therapies, vaccines and blood products in the bio-pharmaceutical industry
  • High sales drive the demand of global export import of Bio-pharmaceutical product
  • Rising importance of fast-track assistance in the healthcare sector
• Market Restraints
  • High cost of transportation
• Market Opportunities
  • Ongoing innovations in the logistics and integration of cloud computing
  • Growing demand for outsourcing transportation services
• Market Challenges
  • Inefficient products and fluctuation in the pricing policies

Porter's Five Forces: A Strategic Tool for Navigating the Bio-Pharmaceutical Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bio-Pharmaceutical Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bio-Pharmaceutical Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bio-Pharmaceutical Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bio-Pharmaceutical Logistics Market

A detailed market share analysis in the Bio-Pharmaceutical Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bio-Pharmaceutical Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bio-Pharmaceutical Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bio-Pharmaceutical Logistics Market

A strategic analysis of the Bio-Pharmaceutical Logistics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bio-Pharmaceutical Logistics Market, highlighting leading vendors and their innovative profiles. These include AmerisourceBergen Corporation, Bio Pharma Logistics, BL Turkey, C.H. Robinson Worldwide, Inc., CAVALIER LOGISITICS, Ceva Logistics LLC, DB Schenker AG, Deutsche Post DHL Group, Fedex Corporation, Kerry Logistics Network Limited, Kuhne + Nagel Management AG, Nippon Express Co., Ltd., Sentry BioPharma Services, Inc., and United Parcel Service of America, Inc..

Market Segmentation & Coverage

This research report categorizes the Bio-Pharmaceutical Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Branded Drugs and Generic Drugs.
• Based on Transport, market is studied across Cold-Chain Transport and Non Cold-Chain Transport.
• Based on Mode of Transportation, market is studied across Air Shipping, Rail Shipping, Road Shipping, and Sea Shipping.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expansion in the demand for cellular therapies, vaccines and blood products in the bio-pharmaceutical industry
    • 5.1.1.2. High sales drive the demand of global export import of Bio-pharmaceutical product
    • 5.1.1.3. Rising importance of fast-track assistance in the healthcare sector
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of transportation
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovations in the logistics and integration of cloud computing
    • 5.1.3.2. Growing demand for outsourcing transportation services
  • 5.1.4. Challenges
    • 5.1.4.1. Inefficient products and fluctuation in the pricing policies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bio-Pharmaceutical Logistics Market, by Product

• 6.1. Introduction
• 6.2. Branded Drugs
• 6.3. Generic Drugs

7. Bio-Pharmaceutical Logistics Market, by Transport

• 7.1. Introduction
• 7.2. Cold-Chain Transport
• 7.3. Non Cold-Chain Transport

8. Bio-Pharmaceutical Logistics Market, by Mode of Transportation

• 8.1. Introduction
• 8.2. Air Shipping
• 8.3. Rail Shipping
• 8.4. Road Shipping
• 8.5. Sea Shipping

9. Americas Bio-Pharmaceutical Logistics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bio-Pharmaceutical Logistics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bio-Pharmaceutical Logistics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AmerisourceBergen Corporation
• 2. Bio Pharma Logistics
• 3. BL Turkey
• 4. C.H. Robinson Worldwide, Inc.
• 5. CAVALIER LOGISITICS
• 6. Ceva Logistics LLC
• 7. DB Schenker AG
• 8. Deutsche Post DHL Group
• 9. Fedex Corporation
• 10. Kerry Logistics Network Limited
• 11. Kuhne + Nagel Management AG
• 12. Nippon Express Co., Ltd.
• 13. Sentry BioPharma Services, Inc.
• 14. United Parcel Service of America, Inc.